CITRO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.458
EU - Europa 2.109
AS - Asia 1.817
SA - Sud America 226
Continente sconosciuto - Info sul continente non disponibili 198
AF - Africa 48
OC - Oceania 21
Totale 6.877
Nazione #
US - Stati Uniti d'America 2.377
IT - Italia 805
SG - Singapore 553
CN - Cina 516
DE - Germania 389
GB - Regno Unito 236
BR - Brasile 195
HK - Hong Kong 176
RU - Federazione Russa 142
VN - Vietnam 136
FR - Francia 115
IN - India 106
NL - Olanda 95
BD - Bangladesh 94
IE - Irlanda 70
SE - Svezia 69
FI - Finlandia 63
CA - Canada 55
ID - Indonesia 48
KR - Corea 37
TR - Turchia 32
JP - Giappone 25
AT - Austria 23
AU - Australia 21
BE - Belgio 16
UA - Ucraina 15
ZA - Sudafrica 14
CI - Costa d'Avorio 12
MX - Messico 11
PL - Polonia 11
CH - Svizzera 10
TH - Thailandia 10
TW - Taiwan 10
AR - Argentina 9
ES - Italia 8
NO - Norvegia 8
PH - Filippine 8
IR - Iran 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
EG - Egitto 6
RO - Romania 6
SA - Arabia Saudita 6
CL - Cile 5
EC - Ecuador 5
HU - Ungheria 5
IQ - Iraq 5
UZ - Uzbekistan 5
CO - Colombia 4
DK - Danimarca 4
IL - Israele 4
PY - Paraguay 4
BB - Barbados 3
HR - Croazia 3
KE - Kenya 3
KG - Kirghizistan 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
JO - Giordania 2
KH - Cambogia 2
LK - Sri Lanka 2
LT - Lituania 2
MA - Marocco 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
SC - Seychelles 2
VE - Venezuela 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TC - Turks e Caicos 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.679
Città #
Dallas 354
Milan 346
Singapore 293
Ashburn 281
Frankfurt am Main 224
Southend 161
Hong Kong 157
San Jose 141
Fairfield 132
Chandler 105
Santa Clara 95
Beijing 90
Dublin 70
Hefei 69
Council Bluffs 67
Hanover 64
Los Angeles 64
Woodbridge 60
Houston 53
Wilmington 52
Cambridge 50
Princeton 48
Helsinki 47
Jakarta 44
Seattle 44
New York 40
Ho Chi Minh City 39
The Dalles 36
Hanoi 33
Bengaluru 32
Buffalo 31
Lauterbourg 29
Rome 29
Moscow 28
Chicago 27
Boardman 25
Columbus 25
Munich 24
Seoul 23
São Paulo 23
Des Moines 22
Naples 22
Ann Arbor 20
London 20
Atlanta 19
Amsterdam 17
Guangzhou 16
Vienna 15
Montreal 14
Toronto 14
Baton Rouge 13
Berlin 13
Eitensheim 13
Abidjan 12
Brescia 12
Istanbul 11
San Diego 11
Shanghai 11
Sydney 11
Redwood City 10
Araruama 9
Cangzhou 9
Johannesburg 9
Nuremberg 9
Phoenix 9
Tokyo 9
Brooklyn 8
Brussels 8
Nanjing 8
North Bergen 8
Turku 8
Warsaw 8
Bodio Lomnago 7
Bologna 7
Fuzhou 7
Memphis 7
New Delhi 7
Philadelphia 7
St Louis 7
Washington 7
Charlotte 6
Da Nang 6
Florence 6
Hyderabad 6
Oslo 6
Piscataway 6
Reggio Emilia 6
Shenzhen 6
Wuhan 6
Ankara 5
Bangkok 5
Biên Hòa 5
Bühl 5
Davis 5
Delhi 5
Denver 5
Genoa 5
Groningen 5
Haiphong 5
Hillsboro 5
Totale 4.118
Nome #
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 704
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way 465
Nanoplastic impact on bone microenvironment: A snapshot from murine bone cells 364
Nanoplastics & health: taking a picture of bone cells 346
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 328
Sex Steroid Regulation of Oxidative Stress in Bone Cells: An In Vitro Study 310
Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour 258
Investigating the Impact of Epstein-Barr Virus on Sphingolipid Composition in Extracellular Vesicles of Multiple Sclerosis Patients 252
Restoring Tissue Homeostasis at Metastatic Sites: A Focus on Extracellular Vesicles in Bone Metastasis 237
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma 232
Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor 202
Extracellular Vesicles as an Innovative Tool for siRNA Delivery to Block the Pathological Communication between Tumor and Microenvironment. 189
RNA medicine: a novel approach to block the pathological communication between tumor and microenvironment 178
The role of NOTCH2 in the Extracellular vesicles mediated communication in Multiple Myeloma: a focus on angiogenesis and osteoclastogenesis 177
The role of NOTCH2 in the extracellular vesicles-mediated angiogenesis and osteoclastogenesis in multiple myeloma 166
Jagged ligands as new targets in multiple myeloma associated angiogenesis 162
The role of Notch pathway in the pro-tumorigenic activity of extracellular vesicles in multiple myeloma 162
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease 160
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase 157
In silico docking of urokinase plasminogen activator and integrins 142
The molecular function and clinical phenotype of partial deletions of the IGF2/H19 imprinting control region depends on the spatial arrangement of the remaining CTCF-binding sites 130
A thermodynamic assay to test pharmacological chaperones for Fabry disease 128
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease 125
Heterodimerization of two pathological mutants enhances the activity of human phosphomannomutase2 125
Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests 123
Inherited and sporadic epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor 121
The analysis of variants in the general population reveals that PMM2 is extremely tolerant to missense mutations and that diagnosis of PMM2-CDG can benefit from the identification of modifiers 115
Drug repositioning can accelerate discovery of pharmacological chaperones 115
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP : possible implications for the disease PMM2-CDG 109
The large phenotypic spectrum of fabry disease requires graduated diagnosis and personalized therapy: A Meta-Analysis can help to differentiate missense mutations 107
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR 97
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo 88
E-Learning for Rare Diseases: An Example Using Fabry Disease 82
In vitro enzyme measurement to test pharmacological Chaperone responsiveness in Fabry and Pompe Disease 69
A splicing mutation of the HMGA2 gene is associated with Silver-Russell syndrome phenotype 68
Main outcomes of the HEBE trial: improving cardiorespiratory fitness and body composition through a tailored feasible lifestyle program 55
Nanoplastics perturb extracellular vesicle-mediated communication in the in vitro and ex vivo bone marrow microenvironment of multiple myeloma 18
Protein Profile of Multiple Myeloma-Derived Extracellular Vesicles for the Discovery of Novel Myeloma-Related Biomarkers 8
null 3
Totale 6.877
Categoria #
all - tutte 21.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022379 0 22 26 26 18 14 26 13 44 50 69 71
2022/2023458 39 28 50 42 51 75 13 29 61 24 30 16
2023/2024609 14 24 31 41 66 20 39 32 32 54 133 123
2024/20251.639 94 169 92 125 106 93 143 142 94 154 209 218
2025/20262.823 268 301 444 235 231 154 315 98 254 173 202 148
2026/2027226 168 58 0 0 0 0 0 0 0 0 0 0
Totale 6.877